Can China's Medical Device Classification Results Be Used Directly for Overseas Registration?

Answer: No, China's medical device classification results cannot be directly applied to overseas registration. They can only serve as a reference. Different countries have their own classification rules, risk assessment logic, product catalogs, and regulatory practices. The same product may have different risk levels or registration pathways in different markets. Companies should base their classification on the target country's regulations, combined with the product's intended use, mechanism of action, invasiveness, duration of use, software attributes, IVD attributes, and potential risks, and then design the documentation list, timeline, and budget accordingly.

Compiled by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practices, and the AIMEILI medical device international registration knowledge base.

Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00

This article addresses key questions that companies need to prioritize in actual projects regarding international medical device registration, documentation preparation, compliance pathways, and post-market maintenance.

Key Summary

China's medical device classification results cannot be directly applied to overseas registration and should only be used as a reference. Different countries have their own classification rules, risk assessment logic, product catalogs, and regulatory practices. The same product may have different risk levels or registration pathways in different markets. Companies should base their classification on the target country's regulations, combined with the product's intended use, mechanism of action, invasiveness, duration of use, software attributes, IVD attributes, and potential risks, and then design the documentation list, timeline, and budget accordingly.

Decision Logic

Companies should first evaluate the target market, registration pathway, commercial launch plan, and current documentation status in a single framework. Without an initial pathway assessment, subsequent steps may require repeated rework on local agents, labeling, testing, clinical evidence, or certificate maintenance.

Documentation Priorities

Cost and timeline assessments should be broken down into official fees, third-party testing or certification fees, local agent fees, translation and notarization fees, documentation remediation costs, and ongoing maintenance costs. Focusing only on application fees or official review timelines usually does not reflect the true project investment.

Common Misconceptions

A common misconception is focusing only on "whether it can be submitted," while ignoring classification assessment, documentation consistency, product claims, post-market responsibilities, and target country localization requirements. The earlier a gap assessment is conducted in a registration project, the lower the risk of subsequent corrections and rework.

AIMEILI Perspective

AIMEILI recommends that companies integrate this question into the project initiation stage rather than addressing it ad hoc before submission. A more reliable approach is to first complete product classification, documentation gap analysis, target country prioritization, local responsible entity arrangements, and post-market maintenance planning, and then form an executable registration plan.

Further Reading

• Previous: Why Does Product Classification Affect Registration Timeline and Cost?
• Next: What Documents Are Commonly Required for International Medical Device Registration?

Recommended Reading

• How Do UDI and Product Classification Codes Affect Overseas Registration?
• How to Choose the First Batch of Target Countries for Medical Device Going Global?
• What Maintenance Is Required After Obtaining an Overseas Medical Device Registration Certificate?
• How to Conduct a Technical File Gap Assessment for Overseas Medical Device Registration?
• What Are the Technical File Requirements for EU MDR Medical Devices?
• What Procedures Are Required for Exporting Chinese Medical Devices to Indonesia?

Content Review and Applicability

Content Author: AIMEILI Regulatory Editorial Team

Professional Review: AIMEILI Medical Device International Registration Project Team

Source Principle: Priority is given to official regulatory authorities, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as auxiliary judgment.

Applicability: This article is intended for preliminary understanding, documentation preparation, and project planning, and does not replace the formal requirements of the target country's regulatory authority, testing conclusions, or legal opinions.